Vitrolife AB (LTS:0YAY) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0YAY Vitrolife AB LTS:0YAY
70 GF Score
Price kr86.05
GF Value kr149.05
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Vitrolife AB FFO per Share?

FFO per Share only applies to REITs.

LTS:0YAY
70GF Score
Vitrolife AB LTS:0YAY
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vitrolife AB (LTS:0YAY) Overvalued in 2026?

Based on GuruFocus' analysis, Vitrolife AB stock appears to be undervalued. The current stock price of kr86.05 is trading 42.3% below its estimated GF Value™ of kr149.05. GuruFocus considers Vitrolife AB to be Possible Value Trap.

Key valuation signals for LTS:0YAY:

  • FFO per Share:
  • GF Value™: kr149.05 vs. price of kr86.05 (42.3% below fair value)
  • GF Score™: 70/100 with 6 warning signs

No single metric tells the full story. See the LTS:0YAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vitrolife AB Business Description

Address Box 9080, Gothenburg, SWE, 400 92
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The company has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.
70GF Score

Get the complete analysis for LTS:0YAY

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr86.05
Price
kr149.05
GF Value